Testing Status of AZT + Nitazoxanide (AIDS Initiative) M970076
CASRN: AZT+NITAZOX
Related: AIDS INITIATIVE
Secondary:
- 30516-87-1 - 3'-Azido-3'-deoxythymidine (AIDS)
- 30516-87-1 - AZT transplacental carcinogenesis study
- 55981-09-4 - Nitazoxanide (AIDS initiative)
Short-Term Toxicity
- 13 weeks (Gavage)
(C98002)
Completed
- Mice: B6C3F1
- Dose: AZT: 0, 200, OR 400 MG/KG/DAY NITAZOXANIDE 250, 500, OR 1000 MG/KG/DAY.
Organ Systems Toxicity
- 28 days Repro/Dev Gen Tox (28-Day) (Gavage)
(RDGT97003)
Completed
- Male and Female Mice: Swiss CD-1
- Dose: NITAZOXANIDE: 250, 500, OR 1000 MG/KG/DAY AZT: 200 OR 400 MG/KG/DAY.